Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure
Robert M Wachter1, Scott A Flanders, Christopher Fee
1University of California, San Francisco, San Francisco, California 94143-0120, USA. bobw@medicine.ucsf.edu
Abstract:
The administration of antibiotics within 4 hours to patients with community-acquired pneumonia has been criticized as a quality standard because it pressures clinicians to rapidly administer antibiotics despite diagnostic uncertainty at the time of patients' initial presentations. The measure was recently revised (to 6 hours) in response to this criticism. On the basis of the experience with the 4-hour rule, the authors make 5 recommendations for the development of future publicly reported quality measures. First, results from samples with known diagnoses should be extrapolated cautiously, if at all, to patients without a diagnosis. Second, for some measures, "bands" of performance may make more sense than "all-or-nothing" expectations. Third, representative end users of quality measures should participate in measure development. Fourth, quality measurement and reporting programs should build in mechanisms to reassess measures over time. Finally, biases, both financial and intellectual, that may influence quality measure development should be minimized. These steps will increase the probability that future quality measures will improve care without creating negative unintended consequences.
Insights
Quality measures for community-acquired pneumonia (CAP) antibiotic timing faced criticism. Recommendations for future measures include cautious extrapolation, performance bands, user input, reassessment, and bias minimization to improve care.
Area of Science:
- Healthcare Quality Improvement
- Clinical Practice Guidelines
- Health Services Research
Background:
- The 4-hour antibiotic administration rule for community-acquired pneumonia (CAP) faced criticism for creating pressure despite diagnostic uncertainty.
- This quality measure was revised to 6 hours in response to clinician feedback and concerns about unintended consequences.
Purpose of the Study:
- To analyze the impact of the 4-hour CAP antibiotic rule and propose recommendations for developing future publicly reported quality measures.
- To enhance the validity and utility of healthcare quality measures by addressing potential flaws in their design and implementation.
Main Methods:
- The study critically evaluated the experience and outcomes associated with the previous 4-hour quality standard for CAP antibiotic administration.
- Recommendations were formulated based on the identified limitations and unintended consequences of the 4-hour rule.
Main Results:
- The 4-hour rule pressured rapid antibiotic use, potentially overriding clinical judgment due to diagnostic uncertainty.
- The measure's revision to 6 hours reflects a response to these criticisms and concerns.
Conclusions:
- Future quality measures should cautiously extrapolate findings from diagnosed samples to undiagnosed populations.
- Consideration of performance "bands" over "all-or-nothing" criteria and inclusion of end-user input are crucial for measure development.
- Mechanisms for ongoing reassessment and minimization of financial/intellectual biases are essential for creating effective quality measures that improve care without negative consequences.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urine Studies II: Urine Culture and Sensitivity Test
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
